Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The renin–angiotensin–aldosterone system (RAAS) is a hormone system that plays a central role in regulating blood pressure, fluid and electrolyte balance, and systemic vascular resistance. It is essential for both acute and chronic control of blood volume and arterial pressure. Dysregulation contributes significantly to hypertension, heart failure progression, chronic kidney disease, and other cardiovascular diseases. Several drug classes target different steps within RAAS: ACE inhibitors, Angiotensin receptor blockers (ARBs), and Direct renin inhibitors.
Pharmacologic inhibition at various points along this pathway.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renin-Angiotensin-Aldosterone System (RAAS).